diagnosis | CARLAT PUBLISHING

Psychopharm Secrets: Side Effects

January 13, 2025

Kellie Newsome, PMHNP and Chris Aiken, MD

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.

Overdiagnosis with Allen Frances

January 6, 2025

Kellie Newsome, PMHNP, Chris Aiken, MD, and Allen Frances, MD

Allen Frances helped create DSM-IV, but in this episode he takes on its diagnostic overreach.

CLINICAL UPDATE

The Psychotherapy of Avoidant Personalities: A Basic Overview

July 11, 2024

Mark L. Ruffalo, MSW, DPsa

Mark L. Ruffalo, MSW, DPsa. Editor in Chief, The Carlat Psychotherapy Report, psychotherapist in private practice in Tampa, Florida, and Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine. He has broad clinical experience in the psychoanalytic treatment of mood, personality, and psychosomatic disorders, and has particular interest in the psychotherapy of schizophrenia and borderline personality disorder.

Dr. Ruffalo has no financial relationships with companies related to this material.

The characteristics, differential diagnosis, theoretical considerations, and treatment approaches for avoidant personality disorder (AvPD), including insights into its prevalence and cultural considerations.

Clinical Update

Managing a Dilemma: Social Contagion Self-Diagnosis in Adolescents and Young Adults

July 1, 2024

Circe Cooke, MD

Circe Cooke, MD. Child and adolescent psychiatrist, Presbyterian Healthcare Services, Albuquerque, NM.

Dr. Cooke has no financial relationships with companies related to this material.

Can kids and teens "catch" mental illness from the internet? This clinical update covers how to assess the degree of media influence on symptoms that children and adolescents report and how to talk with kids and teens about self-diagnoses in a way that builds a collaborative exploratory treatment relationship.

Controversies in Psychiatry

April 8, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Does psychiatry keep making the same mistakes? Edward Shorter gives us a historical perspective.

Expert Q&A

Don’t Forget Fetal Alcohol Spectrum Disorders

January 1, 2024

Ira J. Chasnoff, MD

Ira J. Chasnoff, MD.

Professor of Clinical Pediatrics, University of Illinois College of Medicine, Chicago, IL; President, NTI Upstream, Chicago, IL.

Dr. Chasnoff’s company, NTI Upstream, receives a licensing fee for the 4Ps Plus© screening instrument. Relevant financial relationships listed for the author have been mitigated.

What do you look for to diagnose Fetal Alcohol Spectrum Disorder (FASD)? Read this interview with Dr. Ira Chasnoff to understand the broad impact of FASD and what to look for in the patient’s history (hint: you usually won’t see facial stigmata).

EXPERT Q&A

A Psychiatrist Reflects on Psychotherapy: An Interview with Allen Frances

September 12, 2023

Allen Frances, MD

Allen Frances, MD. Chair of the DSM-IV Task Force; Professor and Chairman Emeritus of the Duke University Department of Psychiatry; founding editor of the Journal of Personality Disorders and the Journal of Psychiatric Practice; and co-host of the podcast Talking Therapy.

Dr. Frances has no financial relationships with companies related to this material.

Dr. Frances explains the rationale for tailored psychotherapy techniques for a strong patient-therapist relationship.

CLINICAL UPDDATE

Bipolar Spectrum Disorders in Children and Adolescents

October 30, 2022

Anthony Charuvastra, MD. Adjunct Assistant Professor, NYU Langone Medical Center Department of Child and Adolescent Psychiatry. New York, NY.

Dr. Charuvastra, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Bipolar disorder is challenging to diagnose in children and adolescents, yet timely and accurate diagnosis is crucial.

How Effective is Atomoxetine in Children and Adolescents

June 27, 2022

Joshua Feder, MD and Mara Goverman

With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine.

Using Clinical Scales in Child Psychiatry

January 31, 2022

Rajeev Krishna, MD, PhD, MBA

Rajeev Krishna, MD, PhD, MBA

Medical Director of Inpatient Services for Behavioral Health at Nationwide Children’s Hospital in Columbus, OH. Dr. Krishna’s comments are his private opinions and do not represent Nationwide Children’s Hospital.

Dr. Krishna has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Clinicians often rely largely on their clinical interview to arrive at a diagnosis and track treatment outcomes. We interviewed Dr. Rajeev Krishna to learn how structured use of assessment scales can improve your diagnostic precision and your outcomes, and how you can build these assessments into your everyday clinical practice.